Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1981 Nov-Dec;54(6):439–446.

The use of D-penicillamine in cystinuria: efficacy and untoward reactions.

E C Halperin, S O Thier, L E Rosenberg
PMCID: PMC2596051  PMID: 7342491

Abstract

A retrospective study was conducted to assess the efficacy of D-penicillamine in the management of cystinuria, as well as to define the frequency and nature of untoward reactions to this drug. Fifty-six individuals were identified who, by stone analysis and/or biochemical studies, met the accepted diagnostic criteria for phenotypic cystinuria. The majority of these patients presented in the second decade of life with evidence of stone formation: renal colic, hematuria, and/or stone passage. Thirty-five individuals were considered to have clinically advanced cystinuria because they had required at least one urinary tract lithotomy. In these advanced cases, frequency of subsequent lithotomies and episodes of renal colic per 100 patient-years of observation were used as indices to measure the efficacy of D-penicillamine treatment. By both measurements, D-penicillamine significantly improved the clinical course of patients. The incidence of acute drug sensitivity reactions (rash, fever, and/or arthropathy) was in excess of 40 percent. Delayed drug-induced proteinuria occurred in 34 percent of treated patients. We conclude that D-penicillamine is useful in the treatment of cystinuria. Because of the significant number of untoward drug reactions, however, we believe the drug should be instituted only in selected, high-risk patients.

Full text

PDF
439

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS D. A., GOLDMAN R., MAXWELL M. H., LATTA H. NEPHROTIC SYNDROME ASSOCIATED WITH PENICILLAMINE THERAPY OF WILSON'S DISEASE. Am J Med. 1964 Feb;36:330–336. doi: 10.1016/0002-9343(64)90096-8. [DOI] [PubMed] [Google Scholar]
  2. CRAWHALL J. C., SCOWEN E. F., WATTS R. W. Effect of penicillamine on cystinuria. Br Med J. 1963 Mar 2;1(5330):588–590. doi: 10.1136/bmj.1.5330.588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DENT C. E., SENIOR B. Studies on the treatment of cystinuria. Br J Urol. 1955 Dec;27(4):317–332. doi: 10.1111/j.1464-410x.1955.tb03486.x. [DOI] [PubMed] [Google Scholar]
  4. Dahlberg P. J., van den Berg, Kurtz S. B., Wilson D. M., Smith L. H. Clinical features and management of cystinuria. Mayo Clin Proc. 1977 Sep;52(9):533–542. [PubMed] [Google Scholar]
  5. Drago J. R., Rohner T. J., Sanford E. J. Cystinuria. Pa Med. 1976 Apr;79(4):59–61. [PubMed] [Google Scholar]
  6. Elsas L. J., Hayslett J. P., Spargo B. H., Durant J. L., Rosenberg L. E. Wilson's disease with reversible renal tubular dysfunction. Correlation with proximal tubular ultrastructure. Ann Intern Med. 1971 Sep;75(3):427–433. doi: 10.7326/0003-4819-75-3-427. [DOI] [PubMed] [Google Scholar]
  7. FLEMING W. H., AVERY G. B., MORGAN R. I., CONE T. E., Jr GASTROINTESTINAL MALABSORPTION ASSOCIATED WITH CYSTINURIA. REPORT OF A CASE IN A NEGRO. Pediatrics. 1963 Sep;32:358–370. [PubMed] [Google Scholar]
  8. Hautmann R., Terhorst B., Stuhlsatz H. W., Lutzeyer W. Mercaptopropionylglycine: a progress in cystine stone therapy. J Urol. 1977 May;117(5):628–630. doi: 10.1016/s0022-5347(17)58562-6. [DOI] [PubMed] [Google Scholar]
  9. Hayslett J. P., Bensch K. G., Kashgarian M., Rosenberg L. E. Focal glomerulitis due to penicillamine. Lab Invest. 1968 Oct;19(4):376–381. [PubMed] [Google Scholar]
  10. Lotz M., Potts J. T., Jr, Holland J. M., Kiser W. S., Bartter F. C. D-penicillamine therapy in cystinuria. J Urol. 1966 Feb;95(2):257–263. doi: 10.1016/S0022-5347(17)63443-8. [DOI] [PubMed] [Google Scholar]
  11. Mulvaney W. P., Quilter T., Mortera A. Experiences with acetylcysteine in cystinuric patients. J Urol. 1975 Jul;114(1):107–108. doi: 10.1016/s0022-5347(17)66955-6. [DOI] [PubMed] [Google Scholar]
  12. Pruzanski W. Cystinuria--report of 56 cases. Urol Int. 1965;20(3):154–162. doi: 10.1159/000279372. [DOI] [PubMed] [Google Scholar]
  13. Remien A., Kallistratos G., Burchardt P. Treatment of cystinuria with Thiola (alpha-mercaptopropionyl glycine). Eur Urol. 1975;1(5):227–228. [PubMed] [Google Scholar]
  14. STERNLIEB I., SCHEINBERG I. H. PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION. JAMA. 1964 Sep 7;189:748–754. doi: 10.1001/jama.1964.03070100042008. [DOI] [PubMed] [Google Scholar]
  15. Smith L. H. Symposium on renal lithiasis. Medical evaluation of urolithiasis. Etiologic aspects and diagnostic evaluation. Urol Clin North Am. 1974 Jun;1(2):241–260. [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES